Skip to main content

Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy

Publication ,  Journal Article
Sun, L; Zhang, W; Tong, Y
Published in: Journal of China Pharmaceutical University
February 1, 2024

S-palmitoylation, a reversible and dynamic post-translational modification in cells, is involved in regulating the transcription and expression of downstream target genes as well as signal transduction, thereby affecting cell life activities. Studies have shown that thousands of human proteins undergo S-palmitoylation modification, suggesting that S-palmitoylation is closely related to the progression and treatment of diseases. T cells play central roles in anti-tumor immune responses. A variety of T cell immune-related proteins are regulated by S-palmitoylation. In the present study, we focus on the impact of S-palmitoylation on T cell signal transduction and its application in T cell immunotherapy, aiming to provide new ideas for the development of new targets and peptide inhibitors for T cell immunotherapy.

Duke Scholars

Published In

Journal of China Pharmaceutical University

DOI

ISSN

1000-5048

Publication Date

February 1, 2024

Volume

55

Issue

1

Start / End Page

45 / 52

Related Subject Headings

  • Pharmacology & Pharmacy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sun, L., Zhang, W., & Tong, Y. (2024). Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy. Journal of China Pharmaceutical University, 55(1), 45–52. https://doi.org/10.11665/j.issn.1000-5048.2023112903
Sun, L., W. Zhang, and Y. Tong. “Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy.” Journal of China Pharmaceutical University 55, no. 1 (February 1, 2024): 45–52. https://doi.org/10.11665/j.issn.1000-5048.2023112903.
Sun L, Zhang W, Tong Y. Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy. Journal of China Pharmaceutical University. 2024 Feb 1;55(1):45–52.
Sun, L., et al. “Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy.” Journal of China Pharmaceutical University, vol. 55, no. 1, Feb. 2024, pp. 45–52. Scopus, doi:10.11665/j.issn.1000-5048.2023112903.
Sun L, Zhang W, Tong Y. Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy. Journal of China Pharmaceutical University. 2024 Feb 1;55(1):45–52.

Published In

Journal of China Pharmaceutical University

DOI

ISSN

1000-5048

Publication Date

February 1, 2024

Volume

55

Issue

1

Start / End Page

45 / 52

Related Subject Headings

  • Pharmacology & Pharmacy